Besides the finding that in patients with JIA in remission, a 12- vs. 6-month withdrawal of MTX did not reduce the relapse rate, it could be demonstrated that higher S100A8/S100A9 concentrations at time of MTX withdrawal were associated with risk of relapse after discontinuing MTX (59). This evidence concerns the gene S100A9 and juvenile idiopathic arthritis.